We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Recommendations for first-line therapy and comorbidities ...

New guidelines and key studies in glycemic control from the 2022 annual meeting of the American Diabetes Association (ADA) are highlighted by Dr Ildiko Lingvay, from the University of Texas ...

This winter, the United States is facing the “Perfect Storm” of COVID, flu and Respiratory Syncytial Virus (RSV). While the White House, HHS, FDA, and a host of governmental agencies focus on this ...

A drug approved to treat Type 2 diabetes is extremely effective at reducing obesity, according to a new study. The drug, called tirzepatide, works on two naturally occurring hormones that help control ...

Disparities in prevalence observed, with higher odds seen among Hispanic, Asian, and Black individuals. HealthDay News — The prevalence of diabetes increased in the United States from 2012 to 2022, ...

Please provide your email address to receive an email when new articles are posted on . “Fatty pancreas is associated with insulin resistance and increased insulin secretion cross-sectionally in ...

Treatment of people with obesity but without diabetes with the glucagon-like peptide-1 (GLP-1) agonist semaglutide (Wegovy) — hailed at its approval in 2021 as a "game changer" for the treatment of ...

Type 1 diabetes is a chronic condition that occurs when the pancreas makes little to no insulin, which causes high blood sugar. Jessica Migala has been a health, fitness, and nutrition writer for ...